| 10.8 |
32.3 |
GO:0060466 |
activation of meiosis involved in egg activation(GO:0060466) |
| 7.3 |
21.9 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 7.3 |
21.9 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 5.1 |
71.2 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 4.8 |
14.4 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 4.7 |
14.1 |
GO:0046959 |
habituation(GO:0046959) |
| 4.6 |
13.7 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 4.5 |
18.0 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 4.3 |
12.8 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 3.9 |
11.7 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 3.8 |
7.7 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 3.2 |
12.7 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 3.1 |
49.9 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 3.0 |
15.0 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 2.9 |
8.8 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 2.9 |
11.6 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 2.8 |
2.8 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 2.8 |
2.8 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 2.8 |
11.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 2.6 |
7.8 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 2.6 |
18.2 |
GO:0045924 |
regulation of female receptivity(GO:0045924) positive regulation of female receptivity(GO:0045925) |
| 2.6 |
12.9 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 2.5 |
40.5 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 2.5 |
7.4 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 2.5 |
19.7 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 2.4 |
9.6 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 2.4 |
35.7 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 2.4 |
2.4 |
GO:0003383 |
apical constriction(GO:0003383) |
| 2.4 |
2.4 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 2.3 |
7.0 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 2.3 |
2.3 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 2.3 |
9.0 |
GO:0021586 |
pons maturation(GO:0021586) |
| 2.2 |
17.9 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 2.2 |
6.6 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 2.1 |
2.1 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 2.1 |
8.5 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 2.1 |
2.1 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 2.1 |
6.2 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 2.0 |
20.2 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 2.0 |
30.1 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 2.0 |
4.0 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 2.0 |
9.9 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 1.9 |
3.8 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 1.9 |
1.9 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 1.9 |
9.4 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.9 |
5.7 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.9 |
9.4 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.9 |
50.3 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 1.9 |
3.7 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 1.8 |
7.4 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 1.8 |
7.2 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 1.8 |
30.5 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.7 |
3.5 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 1.7 |
5.1 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 1.7 |
5.0 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 1.7 |
8.3 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 1.7 |
8.3 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 1.6 |
14.4 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 1.6 |
1.6 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 1.6 |
8.0 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 1.6 |
8.0 |
GO:0015871 |
choline transport(GO:0015871) |
| 1.6 |
4.7 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 1.6 |
18.9 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.6 |
4.7 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 1.6 |
7.8 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.6 |
20.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 1.6 |
4.7 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 1.5 |
4.6 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 1.5 |
4.6 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 1.5 |
1.5 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 1.5 |
4.5 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.5 |
14.8 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 1.5 |
1.5 |
GO:0021604 |
cranial nerve structural organization(GO:0021604) |
| 1.5 |
7.3 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 1.4 |
2.8 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 1.4 |
5.6 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 1.4 |
4.2 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 1.4 |
4.2 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 1.4 |
4.1 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.4 |
2.8 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 1.4 |
2.7 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 1.4 |
1.4 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 1.4 |
4.1 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.3 |
1.3 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 1.3 |
1.3 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 1.3 |
4.0 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 1.3 |
10.5 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 1.3 |
1.3 |
GO:1902336 |
neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
| 1.3 |
6.5 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 1.3 |
3.8 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 1.3 |
3.8 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 1.3 |
3.8 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 1.3 |
6.3 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 1.3 |
3.8 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 1.2 |
6.2 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 1.2 |
13.4 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 1.2 |
1.2 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 1.2 |
15.8 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 1.2 |
6.1 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 1.2 |
7.3 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.2 |
3.6 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 1.2 |
9.7 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 1.2 |
3.6 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 1.2 |
2.4 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 1.2 |
7.2 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 1.2 |
3.6 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 1.2 |
4.7 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 1.2 |
87.9 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 1.2 |
3.5 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 1.2 |
6.9 |
GO:0097107 |
postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
| 1.2 |
2.3 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 1.1 |
3.4 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 1.1 |
4.6 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 1.1 |
3.4 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 1.1 |
3.4 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 1.1 |
2.3 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 1.1 |
5.6 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.1 |
4.5 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 1.1 |
13.5 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.1 |
8.8 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 1.1 |
3.3 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.1 |
4.4 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.1 |
5.4 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 1.1 |
3.3 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 1.1 |
6.5 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 1.1 |
10.8 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 1.1 |
1.1 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.1 |
2.1 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 1.1 |
4.2 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 1.1 |
3.2 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 1.0 |
7.3 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 1.0 |
5.2 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 1.0 |
4.1 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
| 1.0 |
5.1 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.0 |
7.2 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 1.0 |
4.1 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 1.0 |
4.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 1.0 |
9.1 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 1.0 |
17.1 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 1.0 |
12.9 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 1.0 |
14.8 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 1.0 |
8.9 |
GO:0044090 |
positive regulation of vacuole organization(GO:0044090) |
| 1.0 |
7.8 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 1.0 |
2.9 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 1.0 |
2.9 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 1.0 |
1.0 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 1.0 |
1.0 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 1.0 |
8.6 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 1.0 |
26.9 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 1.0 |
12.5 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 1.0 |
2.9 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 1.0 |
1.9 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.9 |
3.8 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.9 |
19.7 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.9 |
0.9 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.9 |
4.7 |
GO:0034183 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.9 |
7.4 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.9 |
4.6 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.9 |
2.7 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.9 |
12.6 |
GO:0001964 |
startle response(GO:0001964) |
| 0.9 |
6.3 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.9 |
4.4 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.9 |
1.8 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.9 |
0.9 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.9 |
5.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.9 |
0.9 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 0.9 |
6.9 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.9 |
4.3 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.9 |
19.7 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.9 |
3.4 |
GO:2000301 |
negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.9 |
4.3 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.8 |
1.7 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) ganglion morphogenesis(GO:0061552) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) dorsal root ganglion development(GO:1990791) |
| 0.8 |
5.9 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.8 |
3.3 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.8 |
2.5 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.8 |
2.5 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.8 |
2.5 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.8 |
3.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.8 |
1.6 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.8 |
3.3 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.8 |
1.6 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.8 |
1.6 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.8 |
3.2 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.8 |
2.4 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.8 |
3.2 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.8 |
4.7 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.8 |
4.7 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.8 |
6.2 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.8 |
0.8 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.8 |
3.1 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.8 |
4.6 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.8 |
6.9 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
| 0.8 |
3.8 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.8 |
6.9 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.8 |
6.1 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.8 |
1.5 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.8 |
2.3 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.8 |
2.3 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.8 |
3.8 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.7 |
3.0 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.7 |
1.5 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.7 |
2.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.7 |
3.7 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.7 |
1.5 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.7 |
2.2 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.7 |
0.7 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 0.7 |
0.7 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.7 |
4.4 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.7 |
2.2 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) protein myristoylation(GO:0018377) |
| 0.7 |
0.7 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.7 |
7.3 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.7 |
2.9 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.7 |
1.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.7 |
2.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.7 |
5.0 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.7 |
2.8 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.7 |
3.5 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.7 |
2.1 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.7 |
2.1 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.7 |
1.4 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.7 |
8.8 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.7 |
6.1 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.7 |
1.3 |
GO:0014887 |
cardiac muscle adaptation(GO:0014887) |
| 0.7 |
0.7 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.7 |
3.3 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.7 |
1.3 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.7 |
3.9 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.7 |
2.6 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.6 |
3.2 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.6 |
2.6 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.6 |
9.7 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.6 |
0.6 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.6 |
3.2 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.6 |
1.3 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.6 |
0.6 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.6 |
1.9 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.6 |
2.5 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.6 |
3.2 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.6 |
1.9 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.6 |
1.9 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.6 |
1.2 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.6 |
3.1 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.6 |
4.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.6 |
1.9 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.6 |
2.5 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.6 |
0.6 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.6 |
1.8 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.6 |
1.8 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.6 |
1.8 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.6 |
1.8 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.6 |
4.8 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.6 |
10.3 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.6 |
0.6 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.6 |
1.8 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.6 |
3.0 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.6 |
6.6 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.6 |
1.8 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.6 |
0.6 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.6 |
3.0 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.6 |
0.6 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.6 |
1.2 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.6 |
10.1 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.6 |
1.8 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.6 |
4.1 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.6 |
9.4 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.6 |
6.4 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.6 |
0.6 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.6 |
0.6 |
GO:0010523 |
negative regulation of calcium ion transport into cytosol(GO:0010523) |
| 0.6 |
1.2 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.6 |
2.3 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.6 |
2.3 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.6 |
1.7 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.6 |
1.7 |
GO:0071336 |
regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.6 |
2.3 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.6 |
1.7 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.6 |
1.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.6 |
4.6 |
GO:0010544 |
negative regulation of platelet activation(GO:0010544) negative regulation of platelet aggregation(GO:0090331) |
| 0.6 |
10.1 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.6 |
0.6 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.6 |
1.7 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.6 |
1.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.6 |
2.8 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.6 |
5.5 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.6 |
3.9 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.6 |
2.8 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.6 |
2.2 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 0.6 |
2.2 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.5 |
17.9 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.5 |
5.4 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.5 |
15.1 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.5 |
6.4 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.5 |
1.6 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.5 |
2.7 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.5 |
1.1 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.5 |
0.5 |
GO:0021826 |
substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.5 |
2.1 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.5 |
8.5 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.5 |
2.6 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.5 |
4.2 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.5 |
1.0 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.5 |
2.6 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.5 |
5.2 |
GO:0034698 |
response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) |
| 0.5 |
2.6 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.5 |
2.1 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.5 |
9.3 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.5 |
2.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.5 |
1.0 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
| 0.5 |
1.0 |
GO:0043369 |
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 0.5 |
4.6 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.5 |
1.0 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.5 |
2.0 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.5 |
1.0 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.5 |
5.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.5 |
5.1 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.5 |
2.0 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.5 |
12.6 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.5 |
1.0 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.5 |
4.0 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.5 |
0.5 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.5 |
2.5 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.5 |
2.5 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.5 |
2.5 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.5 |
1.5 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.5 |
1.0 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.5 |
1.0 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.5 |
1.4 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.5 |
7.7 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.5 |
4.8 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.5 |
0.5 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.5 |
1.4 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.5 |
4.2 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.5 |
1.9 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.5 |
2.8 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.5 |
2.3 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.5 |
0.9 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.5 |
2.8 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.5 |
0.9 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.5 |
0.5 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.5 |
16.4 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.5 |
1.4 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.5 |
2.7 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
| 0.5 |
2.7 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.5 |
3.6 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.4 |
1.3 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.4 |
0.4 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.4 |
4.5 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.4 |
2.7 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.4 |
4.5 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.4 |
6.7 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.4 |
4.9 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.4 |
6.7 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.4 |
1.3 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.4 |
3.5 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.4 |
0.4 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.4 |
2.6 |
GO:1902170 |
cellular response to reactive nitrogen species(GO:1902170) |
| 0.4 |
1.3 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.4 |
20.8 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.4 |
1.7 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 |
1.3 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.4 |
1.3 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.4 |
0.4 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 |
0.4 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.4 |
3.4 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.4 |
1.3 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.4 |
0.9 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
2.6 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.4 |
1.7 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.4 |
4.6 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.4 |
0.8 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.4 |
2.5 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.4 |
0.4 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.4 |
1.3 |
GO:1904192 |
response to L-glutamate(GO:1902065) cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.4 |
1.3 |
GO:0060948 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.4 |
2.1 |
GO:0021592 |
fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
| 0.4 |
5.8 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.4 |
1.2 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.4 |
2.9 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.4 |
1.2 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.4 |
1.6 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.4 |
1.6 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 |
1.2 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.4 |
0.8 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.4 |
2.4 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.4 |
4.0 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.4 |
2.4 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.4 |
0.4 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.4 |
8.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 |
0.8 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 0.4 |
1.6 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.4 |
0.8 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.4 |
1.6 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.4 |
2.7 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.4 |
9.2 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.4 |
1.5 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.4 |
5.0 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.4 |
0.4 |
GO:0072071 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.4 |
3.8 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.4 |
4.6 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.4 |
1.5 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.4 |
2.6 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
| 0.4 |
0.7 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.4 |
5.9 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.4 |
0.7 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 0.4 |
4.4 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.4 |
4.7 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 0.4 |
1.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.4 |
2.9 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.4 |
3.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.4 |
4.3 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.4 |
1.4 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.4 |
0.7 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.4 |
0.7 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.4 |
2.5 |
GO:0086026 |
atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
| 0.4 |
12.3 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 0.3 |
0.7 |
GO:1990035 |
calcium ion import into cell(GO:1990035) |
| 0.3 |
2.4 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.3 |
0.7 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) |
| 0.3 |
1.7 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.3 |
0.7 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.3 |
1.4 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.3 |
0.7 |
GO:0045922 |
negative regulation of fatty acid biosynthetic process(GO:0045717) negative regulation of fatty acid metabolic process(GO:0045922) |
| 0.3 |
0.7 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.3 |
3.1 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.3 |
1.4 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.3 |
1.0 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.3 |
2.0 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.3 |
0.7 |
GO:1903726 |
negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.3 |
0.7 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 |
1.0 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.3 |
0.3 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 |
1.0 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.3 |
0.7 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) regulation of locomotion involved in locomotory behavior(GO:0090325) negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.3 |
3.6 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.3 |
1.7 |
GO:0003344 |
pericardium morphogenesis(GO:0003344) |
| 0.3 |
0.3 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.3 |
0.7 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.3 |
1.6 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.3 |
0.3 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 |
0.3 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.3 |
0.7 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.3 |
2.0 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.3 |
1.0 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 |
3.6 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.3 |
32.9 |
GO:0071804 |
cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.3 |
3.2 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.3 |
3.2 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.3 |
0.3 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.3 |
1.6 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.3 |
2.9 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.3 |
3.2 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.3 |
2.2 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.3 |
0.9 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.3 |
0.3 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.3 |
0.6 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.3 |
0.6 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.3 |
11.5 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.3 |
0.6 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.3 |
1.2 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.3 |
13.3 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.3 |
1.5 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.3 |
0.6 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.3 |
2.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.3 |
1.8 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.3 |
0.3 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.3 |
0.3 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.3 |
0.9 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.3 |
0.6 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 0.3 |
2.4 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.3 |
1.2 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.3 |
4.5 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.3 |
0.3 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.3 |
3.8 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.3 |
1.2 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 |
5.0 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.3 |
2.1 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.3 |
0.9 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.3 |
2.3 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.3 |
1.2 |
GO:0010869 |
regulation of receptor biosynthetic process(GO:0010869) |
| 0.3 |
3.8 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.3 |
0.6 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.3 |
2.0 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.3 |
2.0 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.3 |
5.2 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.3 |
0.9 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.3 |
1.4 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 |
5.7 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.3 |
1.7 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.3 |
1.4 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.3 |
2.5 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.3 |
0.3 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.3 |
1.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.3 |
0.6 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.3 |
8.5 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.3 |
2.5 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.3 |
0.8 |
GO:0072201 |
negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.3 |
1.9 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.3 |
0.3 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.3 |
1.9 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.3 |
0.8 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.3 |
2.4 |
GO:0042119 |
granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
| 0.3 |
0.3 |
GO:0071675 |
regulation of mononuclear cell migration(GO:0071675) |
| 0.3 |
1.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.3 |
0.3 |
GO:1902837 |
import across plasma membrane(GO:0098739) amino acid import into cell(GO:1902837) |
| 0.3 |
1.8 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.3 |
0.3 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.3 |
0.5 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.3 |
0.3 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.3 |
1.0 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.3 |
1.3 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.3 |
0.5 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.3 |
1.0 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.3 |
1.5 |
GO:0010746 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
| 0.3 |
0.8 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 |
2.3 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.3 |
0.8 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.2 |
3.7 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.2 |
0.7 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.2 |
1.5 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 |
0.5 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.2 |
2.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.2 |
0.7 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.2 |
2.4 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.2 |
1.0 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.2 |
0.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.2 |
0.2 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 |
1.0 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 |
0.7 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.2 |
6.7 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.2 |
0.7 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.2 |
0.9 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
14.7 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.2 |
0.7 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.2 |
0.9 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.2 |
1.9 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
0.9 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.7 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.2 |
1.9 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.2 |
2.1 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.2 |
3.5 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.2 |
0.9 |
GO:0001845 |
phagolysosome assembly(GO:0001845) |
| 0.2 |
1.1 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.2 |
0.5 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.2 |
0.9 |
GO:0061718 |
NADH regeneration(GO:0006735) regulation of anion channel activity(GO:0010359) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.2 |
0.9 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.2 |
0.2 |
GO:0046503 |
triglyceride catabolic process(GO:0019433) glycerolipid catabolic process(GO:0046503) |
| 0.2 |
1.4 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 |
1.6 |
GO:0051668 |
localization within membrane(GO:0051668) |
| 0.2 |
0.5 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 |
0.2 |
GO:0099531 |
presynaptic process involved in chemical synaptic transmission(GO:0099531) |
| 0.2 |
5.2 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.2 |
0.7 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.2 |
0.9 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
1.6 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
1.3 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 |
1.1 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.2 |
1.8 |
GO:0070230 |
positive regulation of lymphocyte apoptotic process(GO:0070230) |
| 0.2 |
2.4 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.2 |
1.8 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
0.9 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.2 |
0.9 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.2 |
0.9 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.2 |
1.1 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.2 |
0.2 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 |
2.4 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.2 |
1.3 |
GO:2000058 |
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
| 0.2 |
2.1 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.2 |
0.4 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.2 |
1.9 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 |
0.6 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.2 |
1.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.2 |
27.3 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.2 |
0.2 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.2 |
1.5 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.2 |
0.2 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.2 |
1.3 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.2 |
0.8 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.2 |
1.1 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.2 |
2.3 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.2 |
4.6 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.2 |
0.6 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.2 |
2.5 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 |
4.3 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 |
1.0 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.2 |
1.4 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.2 |
1.4 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 |
1.4 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.2 |
0.6 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 |
0.6 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.2 |
0.4 |
GO:0035787 |
cell migration involved in kidney development(GO:0035787) |
| 0.2 |
1.6 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.2 |
0.6 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.2 |
0.4 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.2 |
3.2 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.2 |
2.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.2 |
0.2 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.2 |
2.9 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.2 |
1.0 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.2 |
3.3 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.2 |
2.1 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.2 |
0.6 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.2 |
0.8 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 |
0.6 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.2 |
0.8 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.2 |
0.6 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 |
0.4 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.2 |
1.5 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.2 |
0.6 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
| 0.2 |
2.8 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 |
0.4 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.2 |
3.0 |
GO:0097576 |
autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.2 |
0.2 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 |
0.6 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 |
0.9 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.2 |
1.1 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 |
1.8 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.2 |
0.9 |
GO:0090234 |
regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.2 |
1.4 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.2 |
1.8 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 0.2 |
0.7 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
0.4 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.2 |
0.9 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 |
1.6 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.2 |
0.5 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.2 |
0.7 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
2.1 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.2 |
0.5 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.2 |
0.3 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 |
0.3 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
12.0 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.2 |
0.5 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 |
0.2 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.2 |
2.3 |
GO:0007188 |
adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
| 0.2 |
0.8 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.2 |
0.2 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.2 |
4.9 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.2 |
0.7 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.2 |
3.7 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.2 |
1.1 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.2 |
0.5 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.2 |
0.3 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.2 |
0.2 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 |
0.3 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.2 |
0.2 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.2 |
1.4 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.2 |
1.1 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 |
0.6 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.2 |
0.3 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.2 |
0.3 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 |
1.7 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.2 |
2.7 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.2 |
1.1 |
GO:0009188 |
ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.1 |
0.6 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.1 |
1.6 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 |
1.2 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.1 |
0.6 |
GO:1902624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
| 0.1 |
2.2 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
0.4 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
2.2 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.7 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.1 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.3 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
0.6 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.1 |
0.3 |
GO:0007031 |
peroxisome organization(GO:0007031) |
| 0.1 |
3.7 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
0.6 |
GO:0034727 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
| 0.1 |
0.7 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.1 |
GO:0033088 |
regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 |
0.8 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
3.5 |
GO:0048167 |
regulation of synaptic plasticity(GO:0048167) |
| 0.1 |
0.8 |
GO:0030838 |
positive regulation of actin filament polymerization(GO:0030838) |
| 0.1 |
0.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.1 |
0.3 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.1 |
0.5 |
GO:0010756 |
regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
0.1 |
GO:0034143 |
regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
| 0.1 |
0.1 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.1 |
0.4 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.1 |
1.3 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.5 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 |
0.5 |
GO:0033275 |
actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.4 |
GO:0090285 |
regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.1 |
0.1 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.1 |
0.8 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
1.2 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.4 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 |
0.5 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.1 |
0.5 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.5 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.1 |
0.4 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.1 |
0.5 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.1 |
0.4 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.1 |
GO:0045988 |
negative regulation of striated muscle contraction(GO:0045988) |
| 0.1 |
1.1 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.9 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
3.7 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.1 |
0.6 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.7 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.6 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
1.2 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.1 |
0.1 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.1 |
0.2 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
0.7 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
3.2 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.4 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.1 |
2.3 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 |
0.5 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.1 |
0.5 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
1.0 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.8 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 |
0.2 |
GO:0010273 |
detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
| 0.1 |
1.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.7 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.1 |
1.0 |
GO:0060079 |
excitatory postsynaptic potential(GO:0060079) |
| 0.1 |
1.6 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
1.1 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.6 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.1 |
0.6 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.1 |
0.5 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.1 |
1.0 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.1 |
0.1 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
0.7 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.5 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
0.4 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
0.2 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.3 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.1 |
0.5 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
1.3 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
0.6 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 |
0.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.3 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.3 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 |
0.4 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
3.5 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.5 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.1 |
0.4 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.4 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.4 |
GO:0090169 |
regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
| 0.1 |
0.3 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
0.4 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
0.7 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.1 |
0.3 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.6 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.2 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.1 |
0.7 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.3 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 |
0.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.3 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
0.1 |
GO:0071404 |
cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.1 |
1.4 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.1 |
0.3 |
GO:0006848 |
pyruvate transport(GO:0006848) |
| 0.1 |
0.3 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.1 |
0.5 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.2 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
0.9 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.1 |
0.4 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
0.2 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.1 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.4 |
GO:0048284 |
organelle fusion(GO:0048284) |
| 0.1 |
0.2 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.3 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.3 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.4 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.6 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 |
0.1 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 |
0.9 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.1 |
0.4 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.3 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.3 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.1 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.1 |
2.0 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
0.2 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
0.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.7 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.8 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.1 |
0.1 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.1 |
0.9 |
GO:1901216 |
positive regulation of neuron death(GO:1901216) |
| 0.1 |
0.4 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.1 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 |
0.4 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.1 |
0.4 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
0.2 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.1 |
0.1 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.2 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 |
1.0 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.3 |
GO:0050672 |
negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.1 |
1.4 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.4 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.1 |
0.3 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
0.2 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.1 |
0.2 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.1 |
0.2 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.7 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
1.5 |
GO:0031333 |
negative regulation of protein complex assembly(GO:0031333) |
| 0.1 |
0.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.6 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.1 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.1 |
0.3 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
0.2 |
GO:0051900 |
regulation of mitochondrial depolarization(GO:0051900) |
| 0.1 |
0.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.4 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.1 |
0.4 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.2 |
GO:0002446 |
neutrophil mediated immunity(GO:0002446) |
| 0.1 |
0.1 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
1.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.9 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.2 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.0 |
0.2 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 |
0.2 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.3 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.8 |
GO:0032507 |
maintenance of protein location in cell(GO:0032507) |
| 0.0 |
0.1 |
GO:0060547 |
negative regulation of necroptotic process(GO:0060546) negative regulation of necrotic cell death(GO:0060547) |
| 0.0 |
1.4 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
1.3 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 |
0.2 |
GO:0045346 |
regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.2 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.2 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.5 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.0 |
0.6 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 |
0.0 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.0 |
0.9 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.0 |
0.2 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.0 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.0 |
0.8 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.0 |
0.2 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.0 |
0.2 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 |
0.1 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.0 |
0.4 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.0 |
0.1 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.0 |
0.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
0.5 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.3 |
GO:0051127 |
regulation of actin nucleation(GO:0051125) positive regulation of actin nucleation(GO:0051127) |
| 0.0 |
1.3 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.0 |
0.1 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.0 |
0.2 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.0 |
0.2 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.1 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.0 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.3 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.1 |
GO:0006900 |
membrane budding(GO:0006900) |
| 0.0 |
0.1 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
2.4 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
0.2 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.0 |
0.1 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 |
0.2 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.0 |
0.0 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.0 |
0.1 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.0 |
0.0 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.0 |
0.2 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.1 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.1 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 |
1.3 |
GO:0006497 |
protein lipidation(GO:0006497) |
| 0.0 |
0.1 |
GO:0006598 |
polyamine catabolic process(GO:0006598) spermine catabolic process(GO:0046208) |
| 0.0 |
0.1 |
GO:0045908 |
negative regulation of vasodilation(GO:0045908) |
| 0.0 |
0.6 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.0 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.1 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.1 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 |
0.1 |
GO:0007595 |
lactation(GO:0007595) |
| 0.0 |
0.1 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 |
0.2 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.0 |
0.1 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.0 |
0.5 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.0 |
0.2 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.2 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
1.5 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.0 |
0.1 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.2 |
GO:0033866 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 |
0.3 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.1 |
GO:0030833 |
regulation of actin filament polymerization(GO:0030833) |
| 0.0 |
0.0 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
| 0.0 |
0.2 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.0 |
0.1 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.0 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.0 |
0.0 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.0 |
0.2 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
0.6 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.0 |
0.0 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.0 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
0.1 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.0 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.2 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.0 |
0.1 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.0 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.0 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.0 |
0.0 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.1 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.3 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
